Pharmacy Times August 20, 2025
An expert shares how 340B puts independent pharmacies at a competitive disadvantage.
In an interview with Pharmacy Times®, Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, discussed how the 340B program was originally intended to support independent pharmacies, but its expansion has largely shifted contracts to big chains and mail-order pharmacies, leaving independents at a disadvantage. He noted that covered entities can buy drugs at deep discounts and resell them at higher commercial rates, generating significant profits in partnership with contract pharmacies. According to Gremminger, pharmacies inside the 340B space benefit from strong margins, while those outside—especially independents without PBM affiliations—struggle with underpayment. He added that pharmacists often face difficult situations when 340B incentives lead...
Today's Sponsors
Today's Sponsor